Filing Details

Accession Number:
0001179110-11-006920
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-26 21:44:19
Reporting Period:
2011-04-20
Filing Date:
2011-04-26
Accepted Time:
2011-04-26 21:44:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1157601 Synta Pharmaceuticals Corp SNTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325718 Keizo Koya C/O Synta Pharmaceuticals Corp.
45 Hartwell Avenue
Lexington MA 02421
Sr. Vp, Drug Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-04-20 10,000 $5.60 29,843 No 4 S Direct
Common Stock Disposition 2011-04-25 10,000 $6.00 19,843 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2010.